These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20226329)

  • 1. Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial.
    Hilden J; Lind I; Kolmos HJ; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Jensen GB; Kastrup J; Kjøller E; Nielsen H; Petersen L; Jespersen CM; Gluud C;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):385-92. PubMed ID: 20226329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
    Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
    Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
    Wong BY; Gnarpe J; Teo KK; Ohman EM; Prosser C; Gibler WB; Langer A; Chang WC; Armstrong PW
    Am Heart J; 2002 Dec; 144(6):987-94. PubMed ID: 12486422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
    Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
    Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
    Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement.
    Arcari CM; Gaydos CA; Nieto FJ; Krauss M; Nelson KE
    Clin Infect Dis; 2005 Apr; 40(8):1123-30. PubMed ID: 15791511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases.
    Turkoglu C; Sonmez E; Aydinli A
    New Microbiol; 2004 Jul; 27(3):229-34. PubMed ID: 15460525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of chlamydial LPS antibodies in patients with acute coronary syndrome without detection of chlamydial DNA in atherectomy samples.
    Kiss K; Khanakah G; Kundi M; Glogar HD; Stanek G
    Wien Klin Wochenschr; 2001 Oct; 113(19):731-6. PubMed ID: 11715751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
    Westerhout CM; Gnarpe J; Chang WC; FitzPatrick S; Barnathan ES; Boersma E; Califf RM; Wallentin L; Simoons ML; Armstrong PW;
    Am Heart J; 2007 Aug; 154(2):306-12. PubMed ID: 17643581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
    Tanne D; Haim M; Boyko V; Goldbourt U; Reshef T; Adler Y; Brunner D; Mekori YA; Behar S
    Cerebrovasc Dis; 2003; 16(2):166-70. PubMed ID: 12792175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of immunoglobulin G antibodies to Chlamydia pneumoniae in acute myocardial infarction patients.
    Ashkenazi H; Rudensky B; Paz E; Raveh D; Balkin JA; Tzivoni D; Yinnon AM
    Isr Med Assoc J; 2001 Nov; 3(11):818-21. PubMed ID: 11729576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of Chlamydia pneumoniae infection and classic coronary risk factors on risk of acute myocardial infarction.
    Kinjo K; Sato H; Sato H; Ohnishi Y; Hishida E; Nakatani D; Mizuno H; Ohgitani N; Kubo M; Shimazu T; Akehi N; Takeda H; Hori M;
    Am Heart J; 2003 Aug; 146(2):324-30. PubMed ID: 12891203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydophila pneumoniae specific antibodies in Thai patients with myocardial infarction.
    Wangroongsarb P; Phuekfen P; Naigowit P; Hagiwara T
    Jpn J Infect Dis; 2002 Apr; 55(2):49-51. PubMed ID: 12082308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease].
    Márk L; Márki-Zay J; Orosz I; Kondacs A; Erdei F; Katona A
    Orv Hetil; 2003 Apr; 144(16):765-8. PubMed ID: 12778627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chlamydia pneumoniae antibody titers in patients with acute ischemic stroke].
    Kawashima N; Kawada J
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1063-8. PubMed ID: 11332184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae and acute coronary syndrome.
    Wong BY; Gnarpe J
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16079381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.